Immunoregulation of lymphokine-activated killer cells
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 49 (1) , 28-40
- https://doi.org/10.1016/0090-1229(88)90092-x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Functional studies on the precursors of human lymphokine-activated killer cellsCellular Immunology, 1985
- Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonatesCellular Immunology, 1985
- Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancerCancer, 1985
- Interferon-independent, lectin-induced augmentation of murine natural killer cell activityInternational Journal of Cancer, 1982
- Hydrocortisone Abrogates Proliferation of T Cells in Autologous Mixed Lymphocyte Reaction by Rendering the Interleukin‐2 Producer T Cells Unresponsive to Interleukin‐1 and Unable to Synthesize the T‐Cell Growth FactorScandinavian Journal of Immunology, 1982
- Suppression of natural killer (NK) cell activity of spleen cells by thymocytesCellular Immunology, 1981
- Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytesNature, 1977